Hyun Bin Lee

Undergraduate intern (2021. 9 - 2022. 2)

MS/PhD Candidate (2022. 3 - Present)

5. Eom, S., Park, S. G., Jun, H., Kim, Y., Lee, H. B., and Kang, S.,* Effective in vivo delivery of diphtheria toxin using protein cage nanoparticles for targeted cancer therapy. Acta Biomater, 2025, 202, 517-528.

4. Lee, H. B., Park, S. G., Kim, H. J., Jeon, J. P., Oh, S., Lee, S., Park, S. H., and Kang, S.,* CD7-Targeted Cytotoxic Potency of Diphtheria Toxin- and Ricin-based Immunotoxins in Targeted Therapy for T-Cell Acute Lymphoblastic Leukemia. Mol. Pharm., 2025, 22, 3255-3267.

3. Kim, Y.,* Kim, J., Eom, S., Jun, H., Lee, H. B., Jeong, D., and Kang, S.,* Protein Nanoparticles Simultaneously Displaying TRAIL and EGFR-Binding Ligands Effectively Induce Apoptotic Cancer Cell Death and Overcome EGFR-TKI Resistance in Lung Cancer. ACS Appl. Mater. Interfaces, 2025, 17, 25139-25151..

2. Park, S. G.,# Lee, H. B.,# and Kang, S.* Development of plug-and-deliverable intracellular protein delivery platforms based on  botulinum neurotoxin. Int. J. Biol. Macromol., 2024, 261, 129622.

# Equal contribution

1. Park, S. G.,# Kim, H. J.,# Lee, H. B., Eom, S., Jun, H., Jang, Y., Park, S. H.* and Kang, S.* Protein cage nanoparticle-based NK cell-engaging nanodrones (NKeNDs) effectively recruit NK cells to target tumor sites and suppress tumor growth. Nano Today, 2024, 54, 102075.